Barclays PLC Moderna, Inc. Call Options Transaction History

Barclays PLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 15, 2024	SELL	$63.64 - $125.14 $16.1 Million - $31.6 Million	-252,700 Reduced 92.67%	20,000 $1.34 Million
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $25.6 Million - $42.1 Million	252,700 Added 1263.5%	272,700 $32.4 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $11.8 Million - $16 Million	-138,700 Reduced 87.4%	20,000 $2.13 Million
Q4 2023 Feb 15, 2024	BUY	$69.51 - $104.43 $11 Million - $16.6 Million	158,700 New	158,700 $15.8 Million
Q1 2023 May 04, 2023	SELL	$135.66 - $197.02 $85.7 Million - $124 Million	-631,700 Reduced 70.44%	265,100 $40.7 Million
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $106 Million - $188 Million	896,800 New	896,800 $161 Million
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $63.8 Million - $96.2 Million	544,700 New	544,700 $77.8 Million

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.